Webinar: From Utah the U.K.—Why Companies Should Consider an IPO on the London Stock Exchange
May 14, 2021
On May 12, 2021, BioUtah presented a webinar featuring representatives of the banking firm, Stifel, as well as James McCullough, CEO of Renalytix, a Utah based company. The webinar presented the opportunity for Utah companies to raise capital through an offering on London Stock Exchange’s AIM platform. Renalytix is one of the most successful companies in years to do just that skipping the traditional process of raising early stage and venture capital.
If you did not have the opportunity to tune in, you can click on the link below to watch the full one hour webinar. It is a unique opportunity for raising capital.
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
